January 18, 2013

The Food and Drug Administration is allowing Roche to tap its reserves of the flu drug Tamiflu, according to published reports.

January 17, 2013

Boehringer Ingelheim Pharmaceuticals has enrolled the first patients in its late-stage trial of a treatment for hepatitis C, the drug maker said Thursday.

January 17, 2013

The Food and Drug Administraiton has approved a drug for replacing clotting proteins in the blood for conditions in which patients have too little of them.

January 17, 2013

More than 5,000 medicines are under development, of which 70% are potentially the first of their class, according to a new report.

January 17, 2013

The dietary supplement industry’s self-regulatory coalition, the SIDI Work Group, announced the release of its voluntary Dietary Supplement Component Supplier Qualification Guideline — a document designed to assist the industry in supply chain integrity, which is a requirement for complying with current good manufacturing practices.

January 16, 2013

The Food and Drug Administration has set user fee rates for generic drug companies, the agency said.

January 16, 2013

New York is hoping to battle the theft of highly addictive prescription drugs, such as Oxycontin, by stocking pharmacies with fake pill bottles that are fitted with GPS tracking devices, according to published reports.

January 15, 2013

The world market for generic drugs will jump more than 15% this year and reach a global total of $127.8 billion, a British market research firm predicted.

January 15, 2013

H. D. Smith announced plans to secure majority ownership in Triplefin, a privately held reimbursement, patient assistance and pharmaceutical brand support services company headquartered in Cincinnati, Ohio.

January 15, 2013

The state supreme court in Alabama ruled that brand-name drug companies could be sued if patients suffer complications from generic versions of their medicines, according to published reports.

January 15, 2013

A drug-security product has won a drug-abuse prevention award.

January 11, 2013

A panel of Food and Drug Administration experts has recommended approval for an experimental Type 2 diabetes drug made by Johnson & Johnson, the drug maker said.

January 11, 2013

Walgreens chief Greg Wasson had a new vision to share with the pharmacy operator's faithful shareholders for 2013. It was a vision that firmly placed the Express Scripts dispute in the rear-view mirror and refocused on the road ahead that includes expanding the role of pharmacy and even what it means to be a U.S. pharmacy operator with its acquisition of Alliance Boots.

Two major announcements were made in the wake of the shareholders meeting, both of which were identified by DSN as two of the top six big trends to watch through 2013. Walgreens reiterated its commitment to fostering an omnichannel experience for its shoppers and, a day after the shareholders meeting, Walgreens became the only retail pharmacy operator to partner on three Accountable Care Organizations.

January 10, 2013

The Food and Drug Administration has approved a new intrauterine device for preventing pregnancy made by Bayer HealthCare Pharmaceuticals, the drug maker said.

January 10, 2013

The Food and Drug Administration has approved a generic epilepsy drug made by Wockhardt, the company said.

January 10, 2013

The Food and Drug Administration is ordering the makers of several sleep drugs to lower the dosage due to the risk that they can impair patients the morning after, the agency said Thursday.

January 9, 2013

"2012 was definitely an important year for Walgreens," Greg Wasson, Walgreens president and CEO, told shareholders here Wednesday afternoon at the chain's annual shareholder meeting. "We did make some tough choices to protect and solidify … our position for the long term," he said. "[But] our vision is crystal clear to become the first choice for health and daily living in America."

January 9, 2013

Generic drug maker Watson Pharmaceuticals has hired a former executive from the Generic Pharmaceutical Association to head lobbying at the federal and state level, the company said.

January 8, 2013

Biotech companies saw a decline in project delays due to regulations over the past year, as more than half have said insurance coverage and reimbursement issues have become more difficult, according to a new report.

January 8, 2013

The Food and Drug Administration on Tuesday advised consumers not to purchase or use “MAXILOSS Weight Advanced” — a product promoted and sold for weight loss on various web sites, including DreamLifeWeightLoss.com, and in some retail stores.

January 8, 2013

Home care provider ResCare HomeCare announced it has signed a national affiliation agreement with Walgreens as the national drug store chain rolls out its DailyMed by Walgreens prescription service.

January 7, 2013

While pressure to grow will drive more large drug makers to pursue mergers and acquisitions, diminished resources and competition from biotech and specialty pharmaceutical companies will challenge their ability to do so, according to a new report.

January 7, 2013

Massachusetts Gov. Deval Patrick has introduced legislation that would give the state government broader power over compounding pharmacies, the governor's office announced.

January 4, 2013

The Food and Drug Administration has approved a new means of administration for a multiple sclerosis drug, the manufacturers said.